MedeSol’s platforms apply anywhere the world relies on disinfection — a combined addressable market of roughly $187 billion. We reach it through three complementary business models.
The global food & beverage disinfection spend our on-site systems and Genesis™ packaging are built to replace — from process water to active packaging.
Pet odor, natural household cleaners, and RV/marine sanitation, led by the OdorSol® consumer line and consumer licensing.
The institutional cleaning-chemical spend our dual-stream on-site systems replace — one installation for disinfection and cleaning alike.
Antiseptics, wound dressings, and disinfectants — addressed through licensing, professional distribution, and on-site generation.
Market figures are total-addressable-market estimates provided as industry context.
We license our patented HOCl Genesis™ chemistry to manufacturers who embed it in their own products — royalties with no cost of goods, across wound care, hygiene, active food packaging, and dental.
MedeSol-branded HOCl across consumer (the OdorSol® line), professional (bottled HOCl for dental and medical distributors), and international channels.
Enterprise systems that generate HOCl on-site, sold with installation and recurring annual service — deployed across food and agriculture, hospitality, and healthcare.
A 15-year exclusive manufacturing agreement with Alden Medical — an FDA-registered, EPA-compliant facility in West Springfield, MA — and a strategic investor holding equity and a board seat.
A validated enterprise installation at one of North America’s largest privately held food-and-agriculture companies delivered a 95%+ reduction in disinfectant cost with a sub-five-month payback.
Formal diligence on wound-care and topical formulations is complete under a signed agreement, with a definitive licensing partnership now advancing.
OdorSol®’s first HOCl Genesis™ product is live on Amazon — the leave-behind chemistry, in a real consumer product. See OdorSol® →
Tell us the application. We’ll share the technical and commercial detail under discussion.
Contact MedeSol →